Skip to main content
Premium Trial:

Request an Annual Quote

Micronics Licenses Biosearch Technologies' Chemistries

NEW YORK (GenomeWeb News) – Point-of-care diagnostic developer Micronics and Biosearch Technologies have struck a license agreement related to nucleic acid assay chemistries, Micronics said today.

Micronics has licensed the right to make, use, and sell products using Biosearch's fluorophores and quencher dyes.

The company is developing a line of point-of-care molecular diagnostic tests for infectious disease diagnosis and forensic testing. Based on Micronics' microfluidic tools that reduce the volume of a sample taken from a patient and the reagents required, the tests will target E. coli, malaria, and respiratory diseases.

Micronics will use Biosearch's Black Hole Quencher, CAL Fluor, and Quasar dye technologies, along with molecular beacons probe technology that Micronics licensed from PHRI Properties.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.